Our mission is to help breast cancer patients live longer, better lives through earlier detection. We combine new deep learning methods, data science and radiology insights to help doctors find malignancies in mammograms. According to external clinical trial results, Kheiron’s deep learning technology achieves state-of-the-art malignancy detection support in breast cancer screening. European regulatory approval is expected shortly.
Location: United Kingdom, England, London
Employees: 11-50
Total raised: $22M
Founded date: 2016
Investors 9
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.09.2019 | Series A | $22M | Atomico |
Mentions in press and media 19
| Date | Title | Description |
| 23.04.2025 | AI Will Shape the Future of Scottish Healthcare, Says New Report | A new report has been published by the Glasgow Centre for Population Health (GCPH) that sheds light on the transformative potential AI could have on Scotland’s public health and healthcare systems. The GCPH report, The Potential of Artifici... |
| 20.02.2025 | Aberdeen’s GEMINI Project Wins Awards for AI Cancer Screening | The team behind the University of Aberdeen’s GEMINI, an AI breast cancer screening project, scooped the ‘Data Driven Innovation Award’ at this year’s Digital Health and Care Awards. The GEMINI (Grampian’s Evaluation of Mia in an Innovative ... |
| 22.03.2024 | A Microsoft-powered medical AI spotted cancer in 11 women where doctors didn't | AI A Microsoft-powered medical AI spotted cancer in 11 women where doctors didn't Mikhaila Friel 2024-03-22T16:19:42Z Share icon An curved arrow pointing right. Share Facebook Icon The letter F. Facebook Email icon An envelope. It indicates... |
| 28.11.2022 | Kheiron Medical Technologies and Microsoft Join Forces To Support Breast Cancer Detection | Kheiron Medical Technologies announced a new technology collaboration with Microsoft that is already supporting the detection of breast cancers alongside radiologists. Kheiron, which has pioneered the development and deployment of an AI sol... |
| 11.05.2022 | Kheiron Medical Technologies Forms US Breast Medical Advisory Board; Appoints Three Leaders With Deep Track Record Advocating For Women's Health | Kheiron announces the appointment of (clockwise from top) Dr. Elizabeth Morris, Dr. Amy Patel, and Dr. Wendy DeMartini to its US Breast Medical Advisory Board. These appointments reinforce Kheiron’s focus on bringing its artificial intellig... |
| 08.04.2022 | A newcomer to AI data labeling, Encord looks to ride a rising tidal wave | Before you can even think about building an algorithm to read an X-ray or interpret a blood smear, the machine has to know what’s what in an image. All of the promise of AI in healthcare — an area that has attracted $11.3 billion in private... |
| 22.11.2021 | Virtual Press Office Exhibitor Profiles: RSNA 2021 | NEW YORK, Nov. 22, 2021 /PRNewswire/ -- The following event roundup from Virtual Press Office is a list of featured exhibitors for RSNA 2021, the place where new ideas and technologies that redefine what it means to work as a radiologist wi... |
| 17.10.2021 | How AI is helping to make breast cancer history | Thomas Clozel Contributor Share on Twitter Thomas Clozel, M.D., is co-founder and CEO of Owkin, former assistant professor of clinical onco-hematology at Hôpital Henri-Mondor in Paris, and former member of the Melnick Lab at Weill Cornell M... |
| 10.12.2020 | U.K. Invests $330 Million To Lead The World In Healthcare AI | In September 2020, NHSX, the organisation driving the digital transformation of health and social ... [+] care, announced that 42 tech companies will receive a share of over £50 million in phase one of its £140m AI in Health and Care Award.... |
| 13.02.2020 | These are the startups on the front lines of the medical imaging space | The amount of funding invested into the space more than doubled in 2018 Misdiagnosis is a major problem in healthcare: not only are 12 million Americans misdiagnosed each year, nearly a third of these cases result in serious injury, or even... |
Show more